Literature DB >> 6576329

[Determination of the degree of morphological regression following chemotherapy in malignant bone tumors].

M Salzer-Kuntschik, G Brand, G Delling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6576329

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


× No keyword cloud information.
  54 in total

1.  Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma.

Authors:  Hyung Jun Im; Tae Sung Kim; Seog-Yun Park; Hye Sook Min; June Hyuk Kim; Hyun Guy Kang; Seung Eun Park; Mi Mi Kwon; Jong Hyung Yoon; Hyeon Jin Park; Seok-ki Kim; Byung-Kiu Park
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-28       Impact factor: 9.236

2.  Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Authors:  Timm Denecke; Patrick Hundsdörfer; Daniel Misch; Ingo G Steffen; Stefan Schönberger; Christian Furth; Michail Plotkin; Juri Ruf; Hubertus Hautzel; Brigitte Stöver; Regine Kluge; Uta Bierbach; Sylke Otto; James F Beck; Christiane Franzius; Günter Henze; Holger Amthauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-27       Impact factor: 9.236

3.  Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment.

Authors:  K Junker; M Thomas; K Schulmann; F Klinke; U Bosse; K M Müller
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

4.  Ewing's sarcoma and primitive neuroectodermal tumor of hand and forearm. Experience of the Cooperative Ewing's Sarcoma Study Group.

Authors:  Wolfgang Daecke; Susanne Ahrens; Herbert Juergens; Abdul-Kader Martini; Volker Ewerbeck; Rainer Kotz; Winfried Winkelmann; Ludger Bernd
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-22       Impact factor: 4.553

5.  Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma.

Authors:  Aleksandar Boro; Matthias Je Arlt; Harald Lengnick; Bernhard Robl; Maren Husmann; Josefine Bertz; Walter Born; Bruno Fuchs
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

6.  The impact of pathological fractures on therapy outcome in patients with primary malignant bone tumours.

Authors:  Babak Moradi; Anita Zahlten-Hinguranage; Burkhard Lehner; Felix Zeifang
Journal:  Int Orthop       Date:  2009-12-13       Impact factor: 3.075

7.  Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80.

Authors:  M Salzer-Kuntschik; G Delling; G Beron; R Sigmund
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

8.  Morphological changes in osteosarcoma after chemotherapy--COSS 80.

Authors:  G Delling; H Krumme; M Salzer-Kuntschik
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

9.  [Therapy-induced tumor regression in adult soft tissue sarcomas-morphological findings].

Authors:  C Kuhnen; K-M Müller; H U Steinau; M Lehnhardt
Journal:  Pathologe       Date:  2004-11       Impact factor: 1.011

10.  Immunohistochemical Estimates of Angiogenesis, Proliferative Activity, p53 Expression, and Multiple Drug Resistance Have No Prognostic Impact in Osteosarcoma: A Comparative Clinicopathological Investigation.

Authors:  Flemming Brandt Sorensen; Kenneth Jensen; Michael Vaeth; Henrik Hager; Anette Mariane Daa Funder; Akmal Safwat; Johnny Keller; Mariann Christensen
Journal:  Sarcoma       Date:  2009-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.